Stablecoin Development Corp (NBY) Form 10-Q — May 15, 2026
Stablecoin Development Corp (formerly NovaBay Pharmaceuticals) reported a dramatic turnaround in its Q1 2026 results, posting a net income of $552.4 million compared to a $3.3 million loss in the same period last year. This surge was driven primarily by a $5.8 billion non-cash gain on the fair value of warrant liabilities, partially offset by a $5.3 billion non-cash loss on warrant issuance, reflecting the complex accounting treatment of its pre-funded warrants following a strategic pivot. The company has fully transitioned from its legacy pharmaceutical business to an on-chain holding company focused on the Sky Protocol ecosystem.
Key figures
- Eps
- 21.23
- Revenue
- 2463000
- Net Income
- 552403000
- Total Debt
- 0
- Cash Position
- 18405000
- Sk Tokens Held
- 2153141678
- Atm Net Proceeds
- 13394000
- Reverse Split Ratio
- 1:5
- Shares Outstanding
- 27115646
- Digital Assets Fair Value
- 160086000
- Private Placement Proceeds
- 134000000
- Warrant Liabilities Fair Value
- 33715000
Price after filing
Close on the filing date to close N calendar days later (from $1.64). Historical, not a forecast.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.